Thrombolytics can provide relative mortality reduction in the treatment of acute myocardial infarction, if patient comes within :
**Core Concept**
Thrombolytic therapy in acute myocardial infarction (AMI) aims to dissolve occluding thrombi, restoring blood flow and reducing infarct size. The efficacy of thrombolytics depends on the time elapsed since symptom onset, which affects the extent of myocardial damage.
**Why the Correct Answer is Right**
Thrombolytics are most effective when initiated within a specific time window, allowing for the greatest reduction in mortality. This is because the longer the delay, the more extensive the myocardial infarction and the less likely the patient is to benefit from thrombolysis. The optimal time window for thrombolytic therapy in AMI is generally considered to be within 3 hours of symptom onset. This is because the chances of successful reperfusion and improved clinical outcomes are highest when treatment is initiated promptly.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specify a time frame, making it ambiguous and unhelpful.
* **Option B:** This option is incorrect because it suggests a longer time window than recommended, which would reduce the effectiveness of thrombolytic therapy.
* **Option C:** This option is incorrect because it implies that thrombolytics are most effective after a prolonged delay, which is contrary to established clinical guidelines.
**Clinical Pearl / High-Yield Fact**
The American Heart Association recommends initiating thrombolytic therapy within 3 hours of symptom onset in patients with ST-elevation myocardial infarction (STEMI) to maximize the benefit.
**Correct Answer: C. 3 hours**